Galmed (GLMD) announced the grant of a new patent related to its lead compound, Aramchol. The patent covers the use of a combination therapy of ...
Plus Texas Health's Surgery Recognition and Medical City Fort Worth's Expansion Milestone.
Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback